Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma

Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network

(2011) V. Audrito et al.   CANCER RESEARCH

Nicotinamide Inhibits Growth of Carcinogen Induced Mouse Bladder Tumor and Human Bladder Tumor Xenograft Through Up-Regulation of RUNX3 and p300

(2011) Wun-Jae Kim et al.   JOURNAL OF UROLOGY

Melanoma stem cells: not rare, but well done

(2011) Sasha D Girouard et al.   LABORATORY INVESTIGATION

Embryonic signaling in melanoma: potential for diagnosis and therapy

(2011) Luigi Strizzi et al.   LABORATORY INVESTIGATION

VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner

(2011) Amalia Vartanian et al.   MELANOMA RESEARCH

Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know

(2011) Steven A. Rosenberg   Nature Reviews Clinical Oncology

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs

(2011) Eyal Greenberg et al.   PLoS One

SIRT1 and p53, effect on cancer, senescence and beyond

(2010) Jingjie Yi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized

(2010) Elsa Quintana et al.   CANCER CELL

Regulation of the Embryonic Morphogen Nodal by Notch4 Facilitates Manifestation of the Aggressive Melanoma Phenotype

(2010) K. M. Hardy et al.   CANCER RESEARCH

Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients

(2010) M. J. Besser et al.   CLINICAL CANCER RESEARCH

Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma

(2010) Peter J. Hoskin et al.   JOURNAL OF CLINICAL ONCOLOGY

Melanoma: A model for testing new agents in combination therapies

(2010) Paolo A Ascierto et al.   Journal of Translational Medicine

3D reconstruction of histological sections: Application to mammary gland tissue

(2010) Ignacio Arganda-Carreras et al.   MICROSCOPY RESEARCH AND TECHNIQUE

Cancer stem cells versus phenotype-switching in melanoma

(2010) Keith S. Hoek et al.   Pigment Cell & Melanoma Research

Intravital Imaging Reveals Transient Changes in Pigment Production and Brn2 Expression during Metastatic Melanoma Dissemination

(2009) S. Pinner et al.   CANCER RESEARCH

Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells

(2009) Rihong Cong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients

(2009) Michal J. Besser et al.   JOURNAL OF IMMUNOTHERAPY

Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system

(2009) Bo Qu et al.   MEDICAL HYPOTHESES

The Vitamin Nicotinamide: Translating Nutrition into Clinical Care

(2009) Kenneth Maiese et al.   MOLECULES

ToppGene Suite for gene list enrichment analysis and candidate gene prioritization

(2009) J. Chen et al.   NUCLEIC ACIDS RESEARCH

‘Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma’

(2009) J L Orgaz et al.   ONCOGENE

Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans

(2008) E. Yiasemides et al.   CARCINOGENESIS

Next Generation of Immunotherapy for Melanoma

(2008) John M. Kirkwood et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting Cancer Stem Cells to Modulate Alternative Vascularization Mechanisms

(2008) Elena Monzani et al.   Stem Cell Reviews and Reports